# Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer

> **NCT05414461** · PHASE2 · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 97 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Combinations

## Key facts

- **NCT ID:** NCT05414461
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-10
- **Primary completion:** 2021-10-17
- **Final completion:** 2022-04-30
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414461, "Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05414461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*